of innovation expenses in 2020
partnerships with industrial partners, academics and start-ups
employees contributing to innovation
The wide range of innovative technologies and solutions in the field of energy transition and in the environment protection, reinforced by the strength of digital and strong integration within the ecosystems, allow the Innovation teams to contribute to the Group’s sustainable growth, which commits to reaching carbon neutrality by 2050.
Approximately 8 billion euros will be invested in the low-carbon hydrogen supply chain by 2035.
Air Liquide purifies biogas from the fermentation of organic and agricultural wastes to obtain biomethane. It is then injected into the domestic grid or liquefied for transportation, storage and distribution as a clean alternative fuel or as industrial fuel.
Air Liquide is one of the world leaders in this constantly changing business sector. The Group is committed, alongside patients, healthcare professionals and hospitals, to contributing to making the healthcare system more efficient, in particular with digital.
In 2020, Air Liquide continued to deploy its medical remote offer Chronic Care Connect Cardiac, for patients with heart failure. It brings together a medical decision support software platform which uses clinical remote medical data processed by predictive algorithms, with a monitoring center in which nurses check the relevance of the alerts generated. The aim of Chronic Care Connect is to improve the quality of patient care, to reduce unplanned hospital readmissions and the associated costs by optimizing care after hospitalization.
A reduction of 21% in the risk of first hospitalization (a)
Digital is now part of all new offers and is also at the heart of all efficiency initiatives, as it allows more efficient processes, a better Customer and User experience and a greater efficiency to enhance operational excellence.
Air Liquide set up the international program Smart & Innovative Operations (SIO) which relies on on data analysis to improve the reliability of oxygen, nitrogen and hydrogen plants and optimize energy consumption.
Air Liquide also brings innovative solutions thanks to the development of deep tech, whether in electronics, extreme cryogenics or space exploration.
The Innovation and Development Division teams gather Research & Development, Digital & IT teams (including Alizent), Global Markets & Technologies, i-lab (our innovation lab focused on understanding the new trends) and ALIAD teams.
Air Liquide has strongly strengthened its partnerships with startups to accelerate innovation and digital transformation for the benefit of the customer experience: the Group is working with more than 100 start-ups worldwide in different ways.
Through ALIAD, the Group’s Venture Capital, Air Liquide supports the growth of technology start-ups by taking minority stakes in them.
Accelair, the Air Liquide deeptech start-up accelerator offers selected start-ups, access to experimental spaces as well as a support program with Air Liquide experts, all with the aim of accelerating time-to-market of their offer.
Working with ecosystems - both internal and external, such as customers, academics, startups, suppliers - is part of our strategy. Developing an inclusive approach is a prerequisite to imagine new solutions meeting user’s needs and behaviors.
Challenging our habits, our ways of working and doing business, and sharing our ideas are the cornerstone of our innovation approach. We develop an entrepreneurial mindset based on a try & learn approach, and are a source of inspiration for the Group.
Credit : Franck Dunouau
We are result-oriented and contribute to the business with operation excellence and sustainable growth. We focus on impactful technologies, including data and AI, and measure the outcomes. With our business entities and Innovation Campuses, we are ultra connected with the business.
Thanks to our proximity with business teams, we start with customer pain points and in-depth understanding of the markets & new usages. We test & iterate with our customers and end-users. Developing a differentiated and unparalleled user experience is our priority.
Credit : Franck Dunouau
(a) OSICAT (Optimisation de la Surveillance ambulatoire des Insuffisants Cardiaques par Télécardiologie) Clinical Trial, issued in 2020, including 990 cardiac patients in France, on the risk of first hospitalization. Although the primary endpoint is not reached, the results show a 21% reduction in the risk of occurrence of the first hospitalization for heart failure.